8-K/A

CURRENT REPORT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: January 10, 2012
Period of Report: January 5, 2012
Accession Number: 0001144204-12-001458

View Document ↗ View on SEC.gov ↗